Characteristic | TB/HIV n (%) | OR (95% CI) | p-value | AOR (95% CI) | p-value |
---|---|---|---|---|---|
Age group (years) | 0.001 | ||||
0–14 | 20 (27.0) | 1 | 1 | ||
15–29 | 35 (13.7) | 0.43 (0.23–0.79) | 0.52 (0.27–1.01) | 0.054 | |
30–49 | 176 (25.0) | 0.90 (0.53–1.55) | 1.15 (0.65–2.05) | 0.632 | |
50–69 | 60 (14.1) | 0.44 (0.25–0.79) | 0.52 (0.28–0.96) | 0.036 | |
≥ 70 | 6 (3.5) | 0.09 (0.04–0.26) | 0.09 (0.04–0.26) | 0.001 | |
Sex | 0.001 | ||||
Male | 162 (15.1) | 1 | 1 | ||
Female | 135 (24.1) | 1.79 (1.38–2.31) | 1.89 (1.44–2.49) | 0.001 | |
Patient category | 0.931 | ||||
New | 275 (93.2) | 1 | |||
Transferred in | 0 | - | |||
Defaulter | 3 (1.0) | 1.50 (0.40–5.58) | |||
Treatment failure | 6 (2.0) | 1.13 (0.46–2.78) | |||
Relapse | 7 (2.4) | 1.09 (0.47–2.51) | |||
Other | 4 (1.8) | 0.72 (0.25–2.09) | |||
TB classification | 0.0015 | ||||
Pulmonary positive | 151 (15.8) | 1 | 1 | ||
Pulmonary negative | 139 (22.5) | 1.54 (1.19–1.99) | 1.84 (1.37–2.47) | 0.001 | |
Extra-pulmonary | 5 (10.4) | 0.62 (0.24–1.59) | 0.58 (0.22–1.55) | 0.279 | |
Treatment District | 0.001 | ||||
Ho | 52 (13.7) | 1 | 1 | ||
Hohoe | 72 (18.5) | 1.44 (0.97–2.12) | 1.69 (1.13–2.54) | 0.011 | |
Kadjebi | 56 (24.9) | 2.09 (1.38–3.19) | 2.29 (1.46–3.57) | 0.001 | |
Keta | 35 (10.8) | 0.77 (0.49–1.21) | 0.62 (0.38–0.99) | 0.047 | |
Kpando | 82 (26.0) | 2.23 (1.51–3.28) | 2.15 (1.44–3.21) | 0.001 | |
Year registrated | 0.419 | ||||
2012 | 105 (19.4) | 1 | |||
2013 | 73 (19.8) | 1.02 (0.73–1.43) | |||
2014 | 53 (15.8) | 0.78 (0.54–1.12) | |||
2015 | 66 (17.0) | 0.85 (0.61–1.19) |